Figure 3.
The improvement in Fugl-Meyer Assessment of the upper extremity (FMA-UE) score was greatest in the BCI-FES group from pre- to post-treatment in patients who started treatment in the acute phase (within one month) post-stroke compared with patients in the Random-FES group and with patients in either group starting treatment in the subacute phase. Including Therapy start as a factor: interaction Time x Group (F(1) = 6.66, p = 0.049; ηp2 = 0.57) (A) Patients starting treatment in the acute phase: post hoc p = 0.016. (B) Patients starting treatment in the subacute phase: post hoc p = 0.78. Error bars = standard error of the mean.